At a CAGR of 19.16% CLL Therapeutics Global Industry Will Grow Steadily During the Period 2016-2020
Cancer that starts from the hematopoietic stem cells of the bone-marrow is referred to as leukemia. Leukemia can be chronic or acute depending on the maturity of the cells. In addition, based on the bone marrow cells from which the cancer starts, leukemia can be categorized as lymphocytic or myeloid.
View full press release